A phase 1 fixed sequence clinical study to determine potential CYP3A4 induction by multiple-dose Remdesivir on Midazolam clearance
Latest Information Update: 27 Jan 2025
Price :
$35 *
At a glance
- Drugs Remdesivir (Primary) ; Midazolam
- Indications COVID 2019 infections
- Focus Pharmacokinetics
- 27 Jan 2025 New trial record